Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| epithelial cell of proximal tubule | 7 studies | 29% ± 17% | |
| type I pneumocyte | 7 studies | 21% ± 4% | |
| adipocyte | 5 studies | 37% ± 17% | |
| astrocyte | 4 studies | 23% ± 4% | |
| dendritic cell | 3 studies | 21% ± 4% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| kidney | 3 studies | 17% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| thymus | 100% | 6356.95 | 653 / 653 | 100% | 39.59 | 602 / 605 |
| breast | 100% | 2871.92 | 459 / 459 | 96% | 32.00 | 1075 / 1118 |
| liver | 97% | 2253.52 | 220 / 226 | 99% | 31.54 | 400 / 406 |
| ovary | 100% | 2350.24 | 180 / 180 | 95% | 20.45 | 409 / 430 |
| uterus | 98% | 1176.48 | 167 / 170 | 94% | 27.24 | 432 / 459 |
| lung | 99% | 2063.26 | 575 / 578 | 91% | 21.34 | 1056 / 1155 |
| bladder | 95% | 2321.00 | 20 / 21 | 95% | 37.30 | 477 / 504 |
| stomach | 95% | 1957.66 | 341 / 359 | 90% | 16.22 | 256 / 286 |
| intestine | 92% | 2181.39 | 884 / 966 | 92% | 16.31 | 483 / 527 |
| pancreas | 89% | 750.56 | 293 / 328 | 94% | 20.23 | 167 / 178 |
| skin | 99% | 2248.38 | 1790 / 1809 | 78% | 13.24 | 367 / 472 |
| brain | 89% | 913.11 | 2348 / 2642 | 87% | 10.33 | 611 / 705 |
| kidney | 100% | 7683.04 | 89 / 89 | 67% | 10.21 | 603 / 901 |
| prostate | 100% | 2896.49 | 244 / 245 | 66% | 7.61 | 330 / 502 |
| esophagus | 82% | 686.96 | 1187 / 1445 | 71% | 8.23 | 130 / 183 |
| adrenal gland | 100% | 9186.96 | 258 / 258 | 43% | 16.65 | 99 / 230 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 17.90 | 29 / 29 |
| spleen | 100% | 1367.85 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 78.47 | 1 / 1 |
| adipose | 100% | 2468.21 | 1200 / 1204 | 0% | 0 | 0 / 0 |
| muscle | 99% | 2549.42 | 791 / 803 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 91% | 10.31 | 41 / 45 |
| blood vessel | 86% | 726.46 | 1144 / 1335 | 0% | 0 | 0 / 0 |
| heart | 86% | 1547.13 | 737 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 59% | 7.61 | 47 / 80 |
| peripheral blood | 48% | 435.37 | 442 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0001676 | Biological process | long-chain fatty acid metabolic process |
| GO_0006631 | Biological process | fatty acid metabolic process |
| GO_0006637 | Biological process | acyl-CoA metabolic process |
| GO_0005759 | Cellular component | mitochondrial matrix |
| GO_0031956 | Molecular function | medium-chain fatty acid-CoA ligase activity |
| GO_0004467 | Molecular function | long-chain fatty acid-CoA ligase activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0005524 | Molecular function | ATP binding |
| Gene name | ACSF2 |
| Protein name | Acyl-CoA synthetase family member 2 Medium-chain acyl-CoA ligase ACSF2, mitochondrial (EC 6.2.1.2) |
| Synonyms | UNQ493/PRO1009 |
| Description | FUNCTION: Acyl-CoA synthases catalyze the initial reaction in fatty acid metabolism, by forming a thioester with CoA . Has some preference toward medium-chain substrates . Plays a role in adipocyte differentiation . . |
| Accessions | H0Y8Y5 D6RF87 ENST00000300441.9 [Q96CM8-1] E7EN53 D6RF15 H0Y8N1 ENST00000427954.6 [Q96CM8-2] ENST00000504392.5 ENST00000508245.5 ENST00000506582.5 ENST00000503408.5 Q96CM8 ENST00000510262.1 E9PF16 ENST00000502667.5 [Q96CM8-3] ENST00000510410.5 |
